Elderly patients denied best treatment for fear of side effects

This release is also available in French, Italian, and German.

Most elderly women with advanced ovarian cancer are not given optimal treatment for fear of an adverse reaction, although there is little evidence to show that they are at greater risk than younger patients, say oncologists in France. The results of an investigation involving 83 women over the age of 70 were announced today (20 October 2002) and will help oncologists identify which patients are most like to benefit from standard chemotherapy.

Speaking at the European Society for Medical Oncology Congress in Nice, France, Dr Gilles Freyer from Centre Hospitalier Lyon Sud, France, said, "We simply do not know if elderly patients can tolerate these powerful drugs, because clinical trials often exclude patients over the age of 70 years, so the results that emerge are not fully representative of the age range of patients we have to treat."

There are a number of factors that have to be taken into account when planning a treatment strategy for older people. They may be more vulnerable to the toxic side effects of the therapy. They experience more psychological problems, such as depression, and it can be difficult for an oncologist to communicate effectively with an elderly person if their cognition is impaired. Transport to and from hospital is one of the practical difficulties for older people.

Patients who are depressed before treatment begins, patients who lack autonomy and those living in institution are at risk of toxicity and the treatment may be less effective. "Perhaps this is because they are more fragile and need more care than elderly women who lead independent lives," Dr Freyer suggested. Medication being taken at the same time for other

Contact: Gracemarie Bricalli
European Society for Medical Oncology

Page: 1 2

Related biology news :

1. Striking A Healthy Balance For The Elderly
2. Dietary Determinants Of Iron Stores In A Free-Living Elderly Population: The Framingham Heart Study
3. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
4. Trial shows which brain cancer patients benefit from temozolomide
5. Study of flu patients reveals virus outsmarting key drug
6. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
7. Activated signaling pathway may predict lung cancer patients response to gefitinib
8. Targeted therapy for lung cancer patients shows promise in extending lives
9. Breast cancer patients failed by treatment with taxol and taxotere respond to abraxane
10. Study finds that only half of a commonly used cancer drug is activated in cancer patients
11. APP reports Abraxane(TM) is active in breast cancer patients who failed taxol or taxotere

Post Your Comments:

(Date:5/7/2019)... ... 07, 2019 , ... Landsec and Spartan Bioscience today announced ... , In May, Landsec will undertake trials using Spartan’s innovative Legionella test. Spartan’s ... take corrective action within hours instead of weeks. This test, if approved, ...
(Date:5/2/2019)... ... 2019 , ... Philadelphia intellectual property law firm Panitch ... Ph.D., a registered patent agent, has joined the firm as a new member ... technical support and scientific expertise in the pharmaceutical and biotechnical arts and assists ...
(Date:5/2/2019)... ... May 01, 2019 , ... Gateway Genomics ... future children, announces a new publication titled, “ Self-Collection of Maternal Blood for ... Child Health. Previous studies had only shown early gender determination using venous blood. ...
Breaking Biology News(10 mins):
(Date:5/14/2019)... ... May 13, 2019 , ... Leak ... instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited ... website aims to improve LDA’s ability to communicate directly with the marketplace; serving ...
(Date:5/4/2019)... ... 03, 2019 , ... Diopsys Inc, the world leader in ... vision test, a new full field electroretinography (ffERG) protocol designed to detect ... Americans will have glaucoma, with black Americans having the highest prevalence rate. This ...
(Date:5/2/2019)... ... 02, 2019 , ... Boston Robotic Hair Restoration announces the ... the days of painful hair transplant procedures. Boston Robotic Hair Restoration offers the ... robotic intelligent solution to offer a minimally invasive procedure. With the ARTAS® iX ...
(Date:4/16/2019)... SAN ANTONIO (PRWEB) , ... April 16, 2019 ... ... biometrics-based human identification systems, applications, and technology, today announced that Bank South Pacific ... through a competitive RFP process. The bank awarded Fulcrum a contract to deliver ...
Breaking Biology Technology:
Cached News: